Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Wolfe Research

Research analysts at Wolfe Research initiated coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a report issued on Monday,Briefing.com Automated Import reports. The brokerage set an “outperform” rating and a $29.00 price target on the stock. Wolfe Research’s price objective would suggest a potential upside of 23.77% from the stock’s previous close.

Several other analysts also recently issued reports on KMTS. The Goldman Sachs Group initiated coverage on shares of Kestra Medical Technologies in a report on Monday. They issued a “neutral” rating and a $24.00 price target on the stock. Stifel Nicolaus began coverage on Kestra Medical Technologies in a report on Monday. They set a “buy” rating and a $28.00 target price on the stock. Wells Fargo & Company initiated coverage on Kestra Medical Technologies in a report on Monday. They issued an “overweight” rating and a $28.00 price target for the company. Finally, Piper Sandler initiated coverage on Kestra Medical Technologies in a research note on Monday. They set an “overweight” rating and a $27.00 price objective on the stock. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $27.67.

Kestra Medical Technologies Stock Performance

NASDAQ:KMTS opened at $23.43 on Monday. Kestra Medical Technologies has a 52-week low of $20.00 and a 52-week high of $25.98.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.